← Open Payments lookup

KIRSTEN MARSHALL: Open Payments

NPI 1124773650 · FULTON, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,478 in 161 payments from 13 companies in 2025. Trend: 2023 $2,187 · 2024 $2,228 · 2025 $2,478

Food & beverage: $2,454Education: $24
CompanyPaymentsAmount
Neurocrine BioSciences, Inc.29$426
Alkermes, Inc.37$348
Janssen Pharmaceuticals, Inc13$306
Vanda Pharmaceuticals Inc.11$259
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)25$240
E.R. Squibb & Sons, L.L.C.6$178
Otsuka America Pharmaceutical, Inc.11$156
Teva Pharmaceuticals USA, Inc.9$142
Axsome Therapeutics, Inc.5$121
Takeda Pharmaceuticals U.S.A., Inc.5$102

Products named: INGREZZA, ARISTADA, INVEGA SUSTENNA, FANAPT, CAPLYTA, COBENFY, REXULTI, Auvelity.

Industry payments across MO — which companies pay providers there.